Short-wavelength automated perimetry and frequency-doubling technology perimetry in glaucoma

Progress in Brain Research

Volumn 173, Issue , 2008, Pages 101-124

  Fogagnolo, Paolo ^a   Rossetti, Luca ^b   Ranno, Stefano ^b   Ferreras, Antonio ^c   Orzalesi, Nicola ^b  

^a IRCCS FONDAZIONE BIETTI   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

^c HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

frequency doubling technology perimetry (FDT); glaucoma; matrix; retinal ganglion cells; short wavelength automated perimetry (SWAP); standard automated perimetry

Indexed keywords

COMPARATIVE STUDY; COMPUTER ASSISTED PERIMETRY; COMPUTER PROGRAM; COST; DIAGNOSTIC ACCURACY; DISEASE COURSE; FREQUENCY DOUBLING TECHNOLOGY PERIMETRY; GLAUCOMA; HUMAN; LONGITUDINAL STUDY; NONHUMAN; PRIORITY JOURNAL; RETINA GANGLION CELL; RETINA RECEPTIVE FIELD; REVIEW; SHORT WAVELENGTH AUTOMATED PERIMETRY; STANDARD AUTOMATED PERIMETRY; VISUAL FIELD;

DISEASE PROGRESSION; GLAUCOMA; HUMANS; PERIMETRY; RETINAL GANGLION CELLS; SOFTWARE; VISUAL FIELDS;

EID: 53049094802     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)01108-4     Document Type: Review

References (106)

1. Anderson A.J., and Johnson C.A. Frequency-doubling technology perimetry and optical defocus. Invest. Ophthalmol. Vis. Sci. 44 (2003) 4147-4152
2. Artes P.H., Hutchison D.M., Nicolela M.T., LeBlanc R.P., and Chauhan B.C. Threshold and variability properties of matrix frequency-doubling technology and standard automated perimetry in glaucoma. Invest. Ophthalmol. Vis. Sci. 46 (2005) 2451-2457
3. Artes P.H., Nicolela M.T., McCormick T.A., LeBlanc R.P., and Chauhan B.C. Effects of blur and repeated testing on sensitivity estimates with frequency doubling perimetry. Invest. Ophthalmol. Vis. Sci. 44 (2003) 646-652
4. Bagga H., Feuer W.J., and Greenfield D.S. Detection of psychophysical and structural injury in eyes with glaucomatous optic neuropathy and normal standard automated perimetry. Arch. Ophthalmol. 124 (2006) 169-176
5. Bayer A.U., and Erb C. Short wavelength automated perimetry, frequency doubling technology perimetry, and pattern electroretinography for prediction of progressive glaucomatous standard visual field defects. Ophthalmology 109 (2002) 1009-1017
6. Bayer A.U., Maag K.P., and Erb C. Detection of optic neuropathy in glaucomatous eyes with normal standard visual fields using a test battery of short-wavelength automated perimetry and pattern electroretinography. Ophthalmology 109 (2002) 1350-1361
7. Bengtsson B., and Heijl A. Normal intersubject threshold variability and normal limits of the SITA SWAP and full threshold SWAP perimetric programs. Invest. Ophthalmol. Vis. Sci. 44 (2003) 5029-5034
8. Bengtsson B., and Heijl A. Diagnostic sensitivity of fast blue-yellow and standard automated perimetry in early glaucoma: a comparison between different test programs. Ophthalmology 13 7 (2006) 1092-1097
9. Blumenthal E.Z., Haddad A., Horani A., and Anteby I. The reliability of frequency-doubling perimetry in young children. Ophthalmology 111 (2004) 435-439
10. Blumenthal E.Z., Sample P.A., Berry C.C., Lee A.C., Girkin C.A., Zangwill L., Caprioli J., and Weinreb R.N. Evaluating several sources of variability for standard and SWAP visual fields in glaucoma patients, suspects, and normals. Ophthalmology 110 (2003) 1895-1902
11. Bowd C., Zangwill L.M., Berry C.C., Blumenthal E.Z., Vasile C., Sanchez-Galeana C., Bosworth C.F., Sample P.A., and Weinreb R.N. Detecting early glaucoma by assessment of retinal nerve fiber layer thickness and visual function. Invest. Ophthalmol. Vis. Sci. 42 9 (2001) 1993-2003
12. Brush M.B., and Chen P.P. Learning effect among perimetric novices with screening C-20-1 frequency doubling technology perimetry. Am. J. Ophthalmol. 137 (2004) 551-552
13. Brusini P. Frequency doubling technology staging system 2. J. Glaucoma 15 (2006) 315-320
14. Brusini P., and Tosoni C. Staging of functional damage in glaucoma using frequency doubling technology. J. Glaucoma 12 5 (2003) 417-426
15. Brusini P., Salvetat M.L., Zeppieri M., and Parisi L. Frequency doubling technology perimetry with the Humphrey Matrix 30-2 test. J. Glaucoma 15 (2006) 77-83
16. Brusini P., Salvetat M.L., Zeppieri M., Tosoni C., Parisi L., and Felletti M. Visual field testing with the new Humphrey Matrix: a comparison between the FDT N-30 and Matrix N-30-F tests. Acta Ophthalmol. Scand. 84 (2006) 351-356
17. Burgansky-Eliash Z., Wollstein G., Patel A., Bilonick R.A., Ishikawa H., Kagemann L., Dilworth W.D., and Schuman J.S. Glaucoma detection with matrix and standard achromatic perimetry. Br. J. Ophthalmol. 91 (2007) 933-938
18. Callaway E.M. Structure and function of parallel pathways in the primate early visual system. J. Physiol. 566 Pt 1 (2005) 13-19
19. Canadian Glaucoma Study: 1. Study design, baseline characteristics, and preliminary analyses. The Canadian Glaucoma Study Group. Can. J. Ophthalmol. 41 (2006) 566-575
20. Chen P.P. Blindness in patients with treated open-angle glaucoma. Ophthalmology 110 (2003) 726-733
21. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am. J. Ophthalmol. 126 (1998) 487-497
22. Contestabile M.T., Perdicchi A., Amodeo S., Recupero V., and Recupero S.M. The influence of learning effect on frequency doubling technology perimetry (Matrix). J. Glaucoma 16 (2007) 297-301
23. Dacey D.M., and Lee B.B. The "blue-on" opponent pathway in primate retina originates from a distinct bistratified ganglion cell type. Nature 367 (1994) 731-735
24. Delgado M.F., Nguyen N.T., Cox T.A., Singh K., Lee D.A., Dueker D.K., Fechtner R.D., Juzych M.S., Lin S.C., Netland P.A., Pastor S.A., Schuman J.S., and Samples J.R. Automated perimetry: a report by the American Academy of Ophthalmology. Ophthalmology 109 (2002) 2362-2374
25. DeMonasterio F.M. Asymmetry of on- and off-pathways of blue-sensitive cones of the retina of macaque. Brain Res. 166 (1979) 39-48
26. Dobkins K.R., and Albright T.D. Merging processing streams: colour clues for motion detection and interpretation. In: Chalupa L.M., and Werner J.S. (Eds). The Visual Neurosciences (2004), The MIT Press, Cambridge, MA 1217-1228
27. Drance S.M., Lakowski R., Schulzer M., and Douglas G.R. Acquired colour vision changes in glaucoma: use of 100-Hue Test and Pickford anomaloscope as predictors of glaucomatous field change. Arch. Ophthalmol. 99 (1981) 829-831
28. Eid T.M., Spaeth G.L., Bitterman A., and Steinmann W.C. Rate and amount of visual loss in 102 patients with open-angle glaucoma followed up for at least 15 years. Ophthalmology 110 (2003) 900-907
29. Eisner A., Toomey M.D., Incognito L.J., O'Malley J.P., and Samples J.R. Contrasting blue-on-yellow with white-on-white visual fields: roles of visual adaptation for healthy peri- or postmenopausal women younger than 70 years of age. Invest. Ophthalmol. Vis. Sci. 47 (2006) 5605-5614
30. Ferreras A., Polo V., Larrosa J.M., Pablo L.E., Pajarin A.B., Pueyo V., and Honrubia F.M. Can frequency-doubling technology and short-wavelength automated perimetries detect visual field defects before standard automated perimetry in patients with preperimetric glaucoma?. J. Glaucoma 16 (2007) 372-383
31. Fogagnolo P., Mazzolani F., Rossetti L., and Orzalesi N. Detecting glaucoma with frequency-doubling technology perimetry a comparison between N-30 and C-20 screening programs. J. Glaucoma 14 (2005) 485-491
32. Forsman E., Kivela T., and Vesti E. Lifetime visual disability in open-angle glaucoma and ocular hypertension. J. Glaucoma 16 (2007) 313-319
33. Friedman D.S., Nordstrom B., Mozaffari E., and Quigley H.A. Glaucoma management among individuals enrolled in a single comprehensive insurance plan. Ophthalmology 112 (2005) 1500-1504
34. Gardiner S.K., Anderson D.R., Fingeret M., McSoley J.J., and Johnson C.A. Evaluation of decision rules for frequency-doubling technology screening tests. Optom. Vis. Sci. 83 (2006) 432-437
35. Girkin C.A., Emdadi A., Sample P.A., Blumenthal E.Z., Lee A.C., Zangwill L.M., and Weinreb R.N. Short-wavelength automated perimetry and standard perimetry in the detection of progressive optic disc cupping. Arch. Ophthalmol. 118 (2000) 1231-1236
36. Gordon M.O., and Kass M.A. The ocular hypertension treatment study: design and baseline description of the participants. Arch. Ophthalmol. 117 (1999) 573-583
37. Gupta N., and Yucel Y.H. What changes can we expect in the brain of glaucoma patients?. Surv. Ophthalmol. 52 suppl 2 (2007) S122-S126
38. Gutierrez P., Wilson M.R., Johnson C., Gordon M., Cioffi G.A., and Ritch R. Influence of glaucomatous visual field loss on health-related quality of life. Arch. Ophthalmol. 115 (1997) 777-784
39. Hartline H.K. The receptive fields of optic nerve fibers. Am. J. Physiol. 130 (1940) 700-711
40. Harwerth R.S., Carter-Dawson L., and Shen F. Ganglion cell losses underlying visual field defects from experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 40 (1999) 2242-2250
41. Hattenhauer M.G., Johnson D.H., Ing H.H., Herman D.C., Hodge D.O., and Yawn B.P. The probability of blindness from open-angle glaucoma. Ophthalmology 105 (1998) 2099-2104
42. Haymes D., Hutchison D.M., McCormick T.A., Varma D.K., Nicolela M.T., LeBlanc R.P., and Chauhan B.C. Glaucomatous visual field progression with frequency-doubling technology and standard automated perimetry in a longitudinal prospective study. Invest. Ophthalmol. Vis. Sci. 46 (2005) 547-554
43. Haymes S.A., Leblanc R.P., Nicolela M.T., Chiasson L.A., and Chauhan B.C. Risk of falls and motor vehicle collisions in glaucoma. Invest. Ophthalmol. Vis. Sci. 48 (2007) 1149-1155
44. Hodapp, E., Parrish II, R. and Anderson, D. (1993) Clinical Decisions in Glaucoma. CV Mosby, St Louis, pp. 11-63.
45. Horn F.K., Brenning A., Jünemann A.G., and Lausen B. Glaucoma detection with frequency doubling perimetry and short-wavelength perimetry. J. Glaucoma 16 (2007) 363-371
46. Horn F.K., Nguyen N.X., Mardin C.Y., and Jünemann A.G. Combined use of frequency doubling perimetry and polarimetric measurements of retinal nerve fiber layer in glaucoma detection. Am. J. Ophthalmol. 135 (2003) 160-168
47. Hosking S.L., and Hilton E.J. Neurotoxic effects of GABA-transaminase inhibitors in the treatment of epilepsy: ocular perfusion and visual performance. Ophthalmic. Physiol. Opt. 22 5 (2002) 440-447
48. Hubel D.H., and Wiesel T.N. Receptive fields of single neurons in the cat's striate cortex. J. Physiol. 148 (1959) 574-591
49. Hutchings N., Hosking S.L., John M., and Flanagan J.G. Long-term fluctuation in short wavelength automated perimetry in glaucoma suspects and glaucoma patients. Invest. Ophthalmol. Vis. Sci. 42 (2001) 2332-2337
50. Jampel H.D., Friedman D.S., Quigley H., and Miller R. Correlation of the binocular visual field with patient assessment of vision. Invest. Ophthalmol. Vis. Sci. 43 (2002) 1059-1067
51. Johnson C.A. Selective versus nonselective losses in glaucoma. J. Glaucoma 3 suppl 1 (1994) 32-44
52. Johnson C.A., and Samuels S.J. Screening for glaucomatous visual field loss with frequency-doubling perimetry. Invest. Ophthalmol. Vis. Sci. 38 (1997) 413-425
53. Johnson C.A., Adams A.J., Casson E.J., and Brandt J.D. Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss. Arch. Ophthalmol. 111 (1993) 645-650
54. Johnson C.A., Adams A.J., Casson E.J., and Brandt J.D. Progression of early glaucomatous visual field loss for blue-on-yellow and standard white-on-white automated perimetry. Arch. Ophthalmol. 111 (1993) 651-656
55. Johnson C.A., Sample P.A., Cioffi G.A., Liebmann J.R., and Weinreb R.N. Structure and function evaluation (SAFE): I. criteria for glaucomatous visual field loss using standard automated perimetry (SAP) and short wavelength automated perimetry (SWAP). Am. J. Ophthalmol. 134 (2002) 177-185
56. Kaplan E. The M, P, K pathways of the primate visual system. In: Chalupa L.M., and Werner J.S. (Eds). The Visual Neurosciences (2004), The MIT Press, Cambridge, MA 481-493
57. Kelly D.H. Frequency doubling in visual responses. J. Opt. Soc. Am. 56 (1966) 1628-1633
58. Keltner J.L., and Johnson C.A. Short-wavelength automated perimetry in neuro-ophthalmologic disorders. Arch. Ophthalmol. 113 4 (1995) 475-481
59. Kim T.W., Zangwill L.M., Bowd C., Sample P.A., Shah N., and Weinreb R.N. Retinal nerve fiber layer damage as assessed by optical coherence tomography in eyes with a visual field defect detected by frequency doubling technology perimetry but not by standard automated perimetry. Ophthalmology 114 (2007) 1053-1057
60. Kuffler S.W. Discharge patterns and functional organization of mammalian retina. J. Neurophysiol. 16 (1953) 37-68
61. Kwon Y.H., Kim C.S., Zimmerman M.B., Alward W.L., and Hayreh S.S. Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma. Am. J. Ophthalmol. 132 (2001) 47-56
62. Landers J.A., Goldberg I.F., and Graham S.L. Detection of early visual field loss in glaucoma using frequency-doubling perimetry and short-wavelength automated perimetry. Arch. Ophthalmol. 121 (2003) 1705-1710
63. Landers J., Sharma A., Goldberg I., and Graham S. Topography of the frequency doubling perimetry visual field compared with that of short wavelength and achromatic automated perimetry visual fields. Br. J. Ophthalmol. 90 (2006) 70-74
64. Lee M.J., Kim D.M., Jeoung J.W., Hwang S.S., Kim T.W., and Park K.H. Localized retinal nerve fiber layer defects and visual field abnormalities by Humphrey Matrix frequency doubling technology perimetry. Am. J. Ophthalmol. 143 (2007) 1056-1058
65. Leeprechanon N., Giaconi J.A., Manassakorn A., Hoffman D., and Caprioli J. Frequency doubling perimetry and short-wavelength automated perimetry to detect early glaucoma. Ophthalmology 114 (2007) 931-937
66. Leske M.C., Heijl A., Hyman L., and Bengtsson B. Early manifest glaucoma trial: design and baseline data. Ophthalmology 106 (1999) 2144-2153
67. Maddess T., and Henry G.H. Performance of nonlinear visual units in ocular hypertension and glaucoma. Clin. Vis. Sci. 7 (1992) 371-383
68. McGwin Jr. G., Owsley C., and Ball K. Identifying crash involvement among older drivers: agreement between self-report and state records. Accid. Anal. Prev. 30 (1998) 781-791
69. McKendrick A.M., Cioffi G.A., and Johnson C.A. Short-wavelength sensitivity deficits in patients with migraine. Arch. Ophthalmol. 120 2 (2002) 154-161
70. Mok K.H., Lee V.W., and So K.F. Retinal nerve fiber layer measurement by optical coherence tomography in glaucoma suspects with short-wavelength perimetry abnormalities. J. Glaucoma 12 (2003) 45-49
71. Musch D.C., Lichter P.R., Guire K.E., and Standardi C.L. The collaborative initial glaucoma treatment study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology 106 (1999) 653-662
72. Nelson P., Aspinall P., Papasouliotis O., Worton B., and O'Brien C. Quality of life in glaucoma and its relationship with visual function. J. Glaucoma 12 (2003) 139-150
73. Oliver J.E., Hattenhauer M.G., Herman D., Hodge D.O., Kennedy R., and Fang-Yen M. Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision. Am. J. Ophthalmol. 133 (2002) 764-772
74. Paczka J.A., Friedman D.S., Quigley H.A., Barron Y., and Vitale S. Diagnostic capabilities of frequency-doubling tecnology, scanning laser polarimetry and nerve fiber layer photograph to distinguish glaucomatous damage. Am. J. Ophthalmol. 131 (2001) 188-197
75. Parrish II R.K., Gedde S.J., Scott I.U., Feuer W.J., Schiffman J.C., and Mangione C.M. Visual function and quality of life among patients with glaucoma. Arch. Ophthalmol. 115 (1997) 1447-1455
76. Polo V., Abecia E., Pablo L.E., Pinilla I., Larrosa J.M., and Honrubia F.M. Short-wavelength automated perimetry and retinal nerve fiber layer evaluation in suspected cases of glaucoma. Arch. Ophthalmol. 116 (1998) 1295-1298
77. Polo V., Larrosa J.M., Pinilla I., Pablo L., and Honrubia F.M. Optimum criteria for short-wavelength automated perimetry. Ophthalmology 108 (2001) 285-289
78. Polo V., Larrosa J.M., Pinilla I., Perez S., Gonzalvo F., and Honrubia F.M. Predictive value of short-wavelength automated perimetry: a 3-year follow-up study. Ophthalmology 109 (2002) 761-765
79. Polyak S.L. The Retina (1941), University of Chicago Press, Chicago
80. Remky A., Arend O., and Hendricks S. Short-wavelength automated perimetry and capillary density in early diabetic maculopathy. Invest. Ophthalmol. Vis. Sci. 41 1 (2000) 274-281
81. Reus N.J., Colen T.P., and Lemij H.G. The prevalence of glaucomatous defects with short-wavelength automated perimetry in patients with elevated intraocular pressures. J. Glaucoma 14 (2005) 26-29
82. Rossetti L., Fogagnolo P., Miglior S., Centofanti M., Vetrugno M., and Orzatesi N. Learning effect of short-wavelength automated perimetry in patients with ocular hypertension. J. Glaucoma 15 5 (2006) 399-404
83. Sample P.A., Bosworth C.F., Blumenthal E.Z., Girkin C., and Weinreb R.N. Visual function specific perimetry for indirect comparison of different ganglion cell populations in glaucoma. Invest. Ophthalmol. Vis. Sci. 41 (2000) 1783-1790
84. Sample P.A., Bosworth C.F., and Weinreb R.N. The loss of visual function in glaucoma. Semin. Ophthalmol. 15 (2000) 182-193
85. Sample P.A., Johnson C.A., Haegerstrom-Portnoy G., and Adams A.J. Optimum parameters for short-wavelength automated perimetry. J. Glaucoma 5 (1996) 375-383
86. Sample P.A., Medeiros F.A., Racette L., Pascual J.P., Boden C., Zangwill L.M., Bowd C., and Weinreb R.N. Identifying glaucomatous vision loss with visual-function-specific perimetry in the diagnostic innovations in glaucoma study. Invest. Ophthalmol. Vis. Sci. 47 (2006) 3381-3389
87. Sánchez-Galeana C.A., Bowd C., Zangwill L.M., Sample P.A., and Weinreb R.N. Short-wavelength automated perimetry results are correlated with optical coherence tomography retinal nerve fiber layer thickness measurements in glaucomatous eyes. Ophthalmology 111 (2004) 1866-1872
88. Shah N.N., Bowd C., Medeiros F.A., Weinreb R.N., Sample P.A., Hoffmann E.M., and Zangwill L.M. Combining structural and functional testing for detection of glaucoma. Ophthalmology 114 (2007) 1414
89. Sherwood M.B., Garcia-Siekavizza A., Meltzer M.I., Hebert A., Burns A.F., and McGorray S. Glaucoma's impact on quality of life and its relation to clinical indicators. A pilot study. Ophthalmology 105 (1998) 561-566
90. Soliman M.A., De Jong L.A., Ismaeil A.A., Van den Berg T.J., and De Smet M.D. Standard achromatic perimetry, short wavelength automated perimetry, and frequency doubling technology for detection of glaucoma damage. Ophthalmology 109 (2002) 444-454
91. Solomon S.G., Barry B.L., Andrew J.R., White L.R., and Martin P.R. Chromatic organization of ganglion cell receptive fields in the peripheral retina. J. Neurosci. 25 (2005) 4527-4539
92. Solomon S.G., White A.J.R., and Martin P.R. Extraclassical receptive fields in primate LGN. J. Neurosci. 22 1 (2002) 338-349
93. Spry P.G., Hussin H.M., and Sparrow J.M. Glaucoma detection with matrix and standard achromatic perimetry. Br. J. Ophthalmol. 91 (2005) 933-938
94. Spry P.G., Hussin H.M., and Sparrow J.M. Performance of the 24-2-5 frequency doubling technology screening test: a prospective case study. Br. J. Ophthalmol. 91 (2007) 1345-1349
95. Szlyk J.P., Mahler C.L., Seiple W., Edward D.P., and Wilensky J.T. Driving performance of glaucoma patients correlates with peripheral visual field loss. J. Glaucoma 14 (2005) 145-150
96. The Advanced Glaucoma Intervention Study (AGIS) 1. Study design and methods and baseline characteristics of study patients. Control Clin. Trials 15 (1994) 299-325
97. Tóth M., Kóthy P., Vargha P., and Holló G. Accuracy of combined GDx-VCC and matrix FDT in a glaucoma screening trial. J. Glaucoma 16 (2007) 462-470
98. Trible J.R., Schultz R.O., Robinson J.C., and Rothe T.L. Accuracy of glaucoma detection with frequency-doubling perimetry. Am. J. Ophthalmol. 129 (2000) 740-745
99. Tyrell R.A., and Owens D.A. A rapid technique to assess the resting states of the eyes and other threshold phenomena: The Modified Binary Search (MOBS). Behav. Res. Methods Instr. Computers 20 (1998) 137-141
100. Weinreb R.N., Lindsey J.D., and Sample P.A. Lateral geniculate nucleus in glaucoma. Am. J. Ophthalmol. 118 (1994) 126-129
101. White A.J., Sun H., Swanson W.H., and Lee B.B. An examination of physiological mechanisms underlying the frequency-doubling illusion. Invest. Ophthalmol. Vis. Sci. 43 (2002) 3590-3599
102. Wild J.M., Cubbidge R.P., Pacey I.E., and Robinson R. Statistical aspects of the normal visual field in short-wavelength automated perimetry. Invest. Ophthalmol. Vis. Sci. 39 1 (1998) 54-63
103. Wild J.M., Kim L.S., Pacey I.E., and Cunliffe I.A. Evidence for a learning effect in short-wavelength automated perimetry. Ophthalmology 113 2 (2006) 206-215
104. Yucel Y.H., Zhang Q., Weinreb R.N., Kaufman P.L., and Gupta N. Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog. Retin. Eye Res. 22 4 (2003) 465-481
105. Zahari M., Mukesh B.N., Rait J.L., Taylor H.R., and McCarty C.A. Progression of visual field loss in open angle glaucoma in the Melbourne Visual Impairment Project. Clin. Experiment Ophthalmol. 34 (2006) 20-26
106. Zangwil L.M.L., Bowd C., and Weinreb R.N. Identifying glaucomatous vision loss with visual-function-specific perimetry in the diagnostic innovations in glaucoma study. Invest. Ophthalmol. Vis. Sci. 47 (2006) 3381-3389